Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
![]() |
Fig. 2 F
Beckers A et al. (2021) |
Xla Wt + foxj1
NF13-21 (in situ hybridization) |
|
|||
![]() |
Fig. 2 b b'
Beckers A et al. (2021) |
Xla Wt + foxj1 CRISPR
NF22-28 (in situ hybridization) |
|
|||
![]() |
Fig. 3 A
Kim H et al. (2021) |
Xla Wt + foxj1 MO
NF13-21 (RT-PCR) |
visceral heterotaxy
situs inversus |
|||
![]() |
Fig. 2 B
Beckers A et al. (2020) |
Xla Wt + foxj1
NF19 (in situ hybridization) |
|
|||
![]() |
Fig. C b b'
Beckers A et al. (2020) |
Xla Wt + foxj1 CRISPR
NF24 (in situ hybridization) |
|
|||
![]() |
Fig. 2. C b b'
Rachev E et al. (2020) |
Xla wt + foxj1 sgnRNA1 CRISPR
NF 24 |
|
|||
![]() |
Fig.1.F
Beckers A et al. (2018) |
Xla Wt + foxj1
NF20 (in situ hybridization) |
|